ADAMTS9-AS1-SEMA3G affects the infiltration of immune cells in pancreatic cancer
10.16571/j.cnki.1008-8199.2020.02.012
- VernacularTitle: ADAMTS9AS1SEMA3G通路对胰腺癌组织中免疫细胞的影响
- Author:
Jia-kang MA
1
;
Kai-kai REN
1
;
Xiao-yan LIN
1
;
Ming-yu HOU
1
;
Bo ZHOU
;
Jun MA
Author Information
1. Department of Oncology, 2
- Publication Type:Journal Article
- Keywords:
pancreatic cancer;
long non-coding RNAs (lncRNAs);
immune infiltration;
pathway;
overall survival
- From:
Journal of Medical Postgraduates
2020;33(2):169-173
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveThe mechanism that affects the infiltration of immune cells in pancreatic cancer has not yet been clarified. This study aims to investigate the lncRNA mRNA regulatory pathways that affect immune infiltration in pancreatic cancer.MethodsTCGA and GEO gene expression data were used to screen common differential lncRNAs. We perform survival analysis, target gene prediction, GO, KEGG enrichment analysis, immune infiltration analysis, gene set enrichment analysis (GSEA) on the selected differential lncRNAs to identify the relevant pathways of immune infiltration.ResultsThe pancreatic cancer patients with high expression of ADAMTS9 AS1 have a higher survival rate when compared to patients with low expression (P=0.010). The combined analysis of TCGA and GSE86436 revealed the difference and survival-related ADAMTS9 AS1. The functional prediction of ADAMTS9 AS1 was related to immunity. Using the TIMER database, the lncRNA affected the infiltration of immune cells in pancreatic cancer tissues. The clinical analysis was demonstrated that the ADAMTS9 AS1 was related to pathological grade. The target gene SEMA3G was screened by co-expression analysis using the IMMPORT database and TIMER database. Lastly, GSEA analysis of ADAMTS9-AS1 showed that the lncRNA was also related to tumor metabolism.ConclusionThese results indicate that ADAMTS9-AS1-SEMA3G is associated with the prognosis and immune invasion level of pancreatic cancer, which can provide a theoretical basis for subsequent genetic verification experiments and immune research.
